Skip to content

Category Archives: Pharmacokinetics

Pharmacokinetics – Distribution Series II – Rate of Drug Distribution

13-Nov-17

Figure 4.1 shows the plasma concentration and the typical tissue concentration profile after the administration of a drug by intravenous injection. It can be seen that during the distribution phase, the tissue concentration increases as the drug distributes to the tissue. Eventually, a type of equilibrium is reached, and following this, in the postdistribution phase, […]

Pharmacokinetics – Distribution Series

11-Nov-17

As a result of either direct systemic administration or absorption from an extravascular route, drug reaches the systemic circulation, where it very rapidly distributes throughout the entire volume of plasma water and is delivered to tissues around the body. Two aspects of drug distribution need to be considered: how radidly, and to what extent, the […]

Variability – Differ in Drug Response

13-Apr-17

Substantial differences in response to drugs commonly exist among patients. Such between or interindividual variability is often reflected by various marketed dose strengths of a drug. Because variability in response within a subject from one occasion to another (intraindividual variability) is generally smaller than interindividual variability, there is usually little need to subsequently adjust an […]

Mass Balance

04-Apr-17

The mass balance technique has been suggested as a more direct alternative to the iterative approach. The mass balance technique is relatively simple and can be best visualized by examining the relationship between the rate of drug administration and the rate of drug elimination. At steady state, the rate of drug elimination (RE) is equal […]

Drug Interactions to Warfarin

22-Mar-17

Drugs may interact with warfarin sodium through pharmacodynamic or pharmacokinetic mechanisms. Pharmacodynamic mechanisms for drug interactions with warfarin sodium are synergism (impaired hemostasis, reduced clotting factor synthesis), competitive antagonism (vitamin K), and alteration of the physiologic control loop for vitamin K metabolism (hereditary resistance). Pharmacokinetic mechanisms for drug interactions with warfarin sodium are mainly enzyme […]